Fact CheckerSign in

NCT03855449Completed

A Task Analysis Study of DECIDE For African American Patients With Type 2 Diabetes

Web-Based Problem Solving Self-Management Program for African Americans With Type 2 Diabetes

Source: ClinicalTrials.gov · Last updated 20 Mar 2026

Brief summary (registry, in English)

The Decision-Making Education for Choices in Diabetes Every Day (DECIDE) program (copyrighted) was created by Dr. Felicia Hill-Briggs and is used by permission for the purpose of this pilot study. This problem-solving curriculum is used to help manage everyday problems when living with diabetes. The purpose of this project is to complete an in-depth review of the Decision-Making Education for Choices in Diabetes Every Day (DECIDE) curriculum, which is delivered in a group face-to-face setting. Using a task analysis process, the investigators will use the findings from the review to develop a web-site version that will be called eDECIDE for use with a community group in Kansas. Phase 3: will be a pilot clinical trial (2 Arm Study) which examines the use of the eDECIDE curriculum compared to the traditional DECIDE curriculum delivered to participants individually.

Status (registry)
Completed
Study type
Interventional
Enrollment
36 (actual)
First submitted
20 Feb 2019
Start date
5 Jun 2019
Primary completion date
30 Oct 2024
Lead sponsor
University of Kansas Medical Center
NCT number
NCT03855449

What you commit to

  • Study type: Interventional
  • Participants enrolled: 36
  • From 5 Jun 2019 to the primary completion date, 30 Oct 2024
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Prior lower extremity amputation

Other illness

  • Severe visual or hearing impairment or any existing condition that would limit or hinder one's ability to use the Internet
  • Dementia
  • Chest pain or angina
  • A diagnosis of a life threatening malignancy within the past year

Lab values

  • Glycosylated hemoglobin HbA1c ≤ 7.0

Other

  • Pregnancy
  • Use of supplemental oxygen

Who the study is looking for

  • African American
  • English speaking
  • Access to the Internet daily
  • Reading level of at least 5th grade
  • Diagnosis of Type 2 Diabetes per one of the following
    • Fasting blood glucose ≥ to 126 mg/dL
    • 2 hr plasma glucose ≥ 200 mg/dL
    • Glycosylated hemoglobin HbA1c ≥ to 6.5%
    • Random plasma glucose ≥ 200 mg/dL

Age in the registry: 16 years to 75 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
University of Kansas Medical Center
Coordinator of this site? Confirm its status
WichitaUnited StatesUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.